메뉴 건너뛰기
Blood
Volumn 116, Issue 9, 2010, Pages 1390-1391
Balancing act for elderly myeloma
Author keywords

[No Author keywords available]
Indexed keywords

EID: 77956567839     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-05-285155     Document Type: Note
Times cited : (2)
References (10)
  • 1
    • 0029548149 scopus 로고
    • Immunomodulation by thalidomide: Systematic review of the literature and of unpublished observations
    • Zwingenberger K, Wnendt S. Immunomodulation by thalidomide: systemic review of the literature and of unpublished observations. J Inflamm. 1995-1996;46(4):177-211. (Pubitemid 26288905)
    • (1995) Journal of Inflammation , vol.46 , Issue.4 , pp. 177-211
    • Zwingenberger, K.1
  • 2
    • 43249097561 scopus 로고    scopus 로고
    • Thalidomide for treatment of multiple myeloma:10 Years later
    • Palumbo A, Facon T, Sonneveld P, et al. Thalidomide for treatment of multiple myeloma:10 years later. Blood. 2008;111(8):3968-3977.
    • (2008) Blood , vol.111 , Issue.8 , pp. 3968-3977
    • Palumbo, A.1    Facon, T.2    Sonneveld, P.3
  • 3
    • 77956599686 scopus 로고    scopus 로고
    • Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma
    • Waage A, Gimsing P, Fayers P, et al. Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma. Blood. 2010;116(9):1405-1412.
    • (2010) Blood , vol.116 , Issue.9 , pp. 1405-1412
    • Waage, A.1    Gimsing, P.2    Fayers, P.3
  • 4
    • 33644843725 scopus 로고    scopus 로고
    • Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: Randomised controlled trial
    • Palumbo A, Bringhen S, Caravita T, et al. Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial. Lancet. 2006;367(9513):825-31.
    • (2006) Lancet , vol.367 , Issue.9513 , pp. 825-831
    • Palumbo, A.1    Bringhen, S.2    Caravita, T.3
  • 5
    • 54049135250 scopus 로고    scopus 로고
    • Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: Updated results of a randomized controlled trial
    • Palumbo A, Bringhen S, Liberati AM, et al. Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial. Blood. 2008;112(8):3107-3114.
    • (2008) Blood , vol.112 , Issue.8 , pp. 3107-3114
    • Palumbo, A.1    Bringhen, S.2    Liberati, A.M.3
  • 6
    • 34848833957 scopus 로고    scopus 로고
    • Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): A randomised trial
    • Facon T, Mary JY, Hulin C, et al. Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial. Lancet. 2007;370(9594):1209-18.
    • (2007) Lancet , vol.370 , Issue.9594 , pp. 1209-1218
    • Facon, T.1    Mary, J.Y.2    Hulin, C.3
  • 7
    • 68949137225 scopus 로고    scopus 로고
    • Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM01/01 Trial
    • Hulin C, Facon T, Rodon P, et al. Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM01/01 Trial. J Clin Oncol. 2009;27(22):3664-3670.
    • (2009) J Clin Oncol , vol.27 , Issue.22 , pp. 3664-3670
    • Hulin, C.1    Facon, T.2    Rodon, P.3
  • 8
    • 64249096177 scopus 로고    scopus 로고
    • Melphalan + prednisone vs melphalan + prednisone + thalidomide in induction therapy for multiple myeloma in elderly patients: First interim results of the Dutch Cooperative Group HOVON
    • abstract. Abstract 0440
    • Wijermans P, Schaafsma M, van Norden Y, et al. Melphalan + prednisone vs melphalan + prednisone + thalidomide in induction therapy for multiple myeloma in elderly patients: first interim results of the Dutch Cooperative Group HOVON [abstract]. Haematologica. 2008;93(s1):178. Abstract 0440.
    • (2008) Haematologica , vol.93 , Issue.S1 , pp. 178
    • Wijermans, P.1    Schaafsma, M.2    Van Norden, Y.3
  • 9
    • 79951894041 scopus 로고    scopus 로고
    • MP versus MPT for previously untreated elderly patients with multiple myeloma: A meta-analysis of 1,682 individual patient data from six randomized clinical trials
    • abstract. Abstract 8130
    • Waage A, Palumbo AP, Fayers P, et al. MP versus MPT for previously untreated elderly patients with multiple myeloma: a meta-analysis of 1,682 individual patient data from six randomized clinical trials [abstract]. J Clin Oncol. 2010(suppl);28:15s. Abstract 8130.
    • (2010) J Clin Oncol , vol.28 , Issue.SUPPL.
    • Waage, A.1    Palumbo, A.P.2    Fayers, P.3
  • 10
    • 77249100430 scopus 로고    scopus 로고
    • Melphalan and prednisone (MP) versus melphalan, prednisone and thalidomide (MPT) as initial therapy for previously untreated elderly and/or transplant ineligible patients with multiple myeloma: A meta-analysis of randomized controlled trials
    • abstract. Abstract 615
    • Kapoor P, Rajkumar SV, Dispenzieri A, et al. Melphalan and prednisone (MP) versus melphalan, prednisone and thalidomide (MPT) as initial therapy for previously untreated elderly and/or transplant ineligible patients with multiple myeloma: a meta-analysis of randomized controlled trials [abstract]. Blood (ASH Annual Meeting Abstracts). 2009;114(22):Abstract 615.
    • (2009) Blood (ASH Annual Meeting Abstracts) , vol.114 , Issue.22
    • Kapoor, P.1    Rajkumar, S.V.2    Dispenzieri, A.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.